Book a Meeting

Anti-ICOS Antibody, Non-Fucosylated (BioBet-1813ZP) (CAT#: BioBet-1813ZP) Datasheet

Target
ICOS
Isotype
IgG
Description
Non-Fucosylated Anti-Human ICOS (MEDI-570) is a glycosylation-modified therapeutic biobetter antibody.
Antibody Indication
Systemic lupus erythematosus;Various stages and grades of T cell lymphoma
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced ICOS antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
ICOS
Full Name
inducible T-cell co-stimulator
Background
The protein encoded by this gene belongs to the CD28 and CTLA-4 cell-surface receptor family. It forms homodimers and plays an important role in cell-cell signaling, immune responses, and regulation of cell proliferation.
Alternative Names
ICOS; inducible T-cell co-stimulator; AILIM; CD278; CVID1; inducible T-cell costimulator; inducible costimulator; activation-inducible lymphocyte immunomediatory molecule
Gene ID
29851
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG
Antibody Clone
MEDI-570
Host
Human
Species Reactivity
Human
Description
This clone was generated using a stable CHO cell line with the FUT8 knockout gene. It was 100% non-fucosylated. In an in vitro cell-based ADCC assay, the afucosylated antibody clone showed significantly higher ADCC activity compared to its wild type version. The binding affinity of the non-fucosylated Fc variant antibody to Fc receptor is much higher than than the same antibody with fucosylated Fc. Robust and stable production of qualitative fully non-fucosylated therapeutic antibodies is achieved.
Antibody Indication
Systemic lupus erythematosus;Various stages and grades of T cell lymphoma

Related Products

Anti-ICOS Antibody, Non-Fucosylated (BioBet-1020ZP) (CAT#: BioBet-1020ZP)
Anti-ICOS Antibody, Non-Fucosylated (BioBet-1022ZP) (CAT#: BioBet-1022ZP)
Anti-ICOS Antibody, Half-Life Extended (AES-0622-ZP1236) (CAT#: AES-0622-ZP1236)
Anti-ICOS Antibody, Non-Fucosylated (BioBet-1019ZP) (CAT#: BioBet-1019ZP)
Anti-ICOS Antibody, Non-Fucosylated (BioBet-1023ZP) (CAT#: BioBet-1023ZP)
Anti-ICOS Antibody, FcγRIIB Binding Enhanced (AES-0622-ZP580) (CAT#: AES-0622-ZP580)
Anti-ICOS Antibody, Recycling (AES-0622-ZP252) (CAT#: AES-0622-ZP252)
Anti-ICOS Antibody, ADCC Enchanced (BioBet-CB-092LX) (CAT#: BioBet-CB-092LX)

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.